Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Emotion Diary Application

7. oktober 2026 oppdatert av: Özge KOKSAL, Gazi University

The Effect of the Emotion Diary Application on Awareness, Emotion Regulation, and Anxiety Levels in Pediatric Patients

Pediatric patients, hospitalization in a pediatric intensive care unit (PICU) is not merely a situation requiring physical treatment, but also an experience that has significant psychosocial effects. This project was designed to evaluate the effect of a mood journal intervention on anxiety levels, mindfulness, and emotion regulation skills in conscious pediatric patients aged 9-14 years in a pediatric intensive care unit. An emotion journal is a supportive tool that allows children to express the experiences they have during the day, the emotions they feel, and their reactions to these emotions in a structured format. It is anticipated that this practice may help children develop their abilities to recognize, express, and regulate their emotions; it may also reduce their anxiety levels related to the intensive care process. Children admitted to the pediatric intensive care unit who are conscious, able to communicate, and meet the inclusion criteria will be assigned to the intervention and control groups using a randomization method. At the start of the study, both groups will be provided with the Child and Parent Information Form, the Child and Adolescent Mindfulness Scale, the Emotion Regulation Scale for Children and Adolescents, and the State Anxiety Scale for Children will be administered to both groups. The intervention group will participate in an emotion journaling program for 5 days, approximately 30 minutes per day, while the control group will receive routine clinical care. Data will be analyzed using the SPSS 30.0 statistical software; descriptive statistics, normality tests, parametric or non-parametric group comparison tests, and correlation analyses will be performed. As a result of the project, it is expected that the emotion journaling intervention will reduce children's anxiety levels, increase their mindfulness, and support their emotion regulation skills. It is anticipated that the findings will contribute to the development of implementable, low-cost, and child-centered psychosocial care interventions in pediatric intensive care units.

Studieoversikt

Studietype

Intervensjonell

Registrering (Antatt)

64

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • ÇANKAYA
      • Ankara, ÇANKAYA, Tyrkia (Türkiye), 06930
        • Ankara Bilkent City Hospital
        • Ta kontakt med:
          • CITY HOSPITAL I Üniversiteler Neighborhood, 6000th Avenue No: 9, Bilkent/Çanka
          • Telefonnummer: 0312 552 60 00
          • E-post: ankarasehir@saglik.gov.tr

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

9 år til 14 år (Barn)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Children aged 9-14 years
  • Those who voluntarily agree to participate in the study
  • Those who are not intubated and are able to communicate
  • Those who are conscious
  • Children admitted to the intensive care unit will be accepted into the study.

Exclusion Criteria:

  • Those with visual, hearing, or neurological/mental impairments that hinder communication;
  • Those with cognitive limitations severe enough to prevent them from responding to the scales;
  • Those under sedation;
  • Children whose clinical condition does not permit the 30-minute intervention; and
  • Children and parents who do not wish to participate in the study.

Withdrawal Criteria:

- Those unable to participate in the program for more than 2 days of the five-day schedule.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Experimental

9-14 years children

Emotion Diary Administration Protocol The emotion diary to be administered to children in the experimental group will be a structured material developed by the researchers. The emotion diary will be administered to children aged 9-14 who are hospitalized in the pediatric intensive care unit, are conscious, able to communicate, and meet the inclusion criteria for the study, for a period of 5 days, for approximately 30 minutes each day. All sessions will be conducted by the researchers; the journal will be completed by the child themselves. The emotion journal is structured to help children become aware of the experiences they go through during their time in intensive care, the emotions they feel, and how these emotions manifest in their bodies and behaviors, and to assist them in developing appropriate coping strategies. The journal will include sections appropriate for the children's age level, such as selecting emotions, naming emotions, written expression, short-answer questions, dr

Ingen inngripen: No Intervention

9-14 years children

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
State Anxiety Scale for Children
Tidsramme: Change relative to the baseline value on day 5

The State Anxiety Scale for Children was developed by Spielberger et al. in 1970.

This scale was developed to assess children's momentary emotional states. Its validity in Turkish was established by Öner and Le Compte in 1985. It was translated into Turkish by Özusta (1995).

The response fields can be extended as needed. The scale consists of 20 items and is designed to assess emotions related to state anxiety. The highest possible score on the scale is 80, and the lowest is 20. A high score indicates a high level of anxiety. The scale's Cronbach's alpha coefficient is 0.89 (Spielberger and Edwards, 1973); in the Turkish version, it is 0.82 (Özusta, 1995).

Change relative to the baseline value on day 5

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Child and Adolescent Mindfulness Scale
Tidsramme: Change relative to the baseline value on day 5

The scale was developed by Greco et al. (2011), and a study on its validity and reliability in Turkish was conducted by Bilaç et al. (2024). Used to measure mindfulness in children and adolescents aged nine and older, the scale consists of 10 items and is a five-point Likert-type self-report scale (4: always, 3: often, 2: sometimes, 1: rarely, 0: never). The items on the scale are first reverse-coded by changing 0 to 4, 1 to 3, 3 to 1, and 4 to 0 (leaving 2 unchanged), and the total score is calculated by summing all items. Higher scores are considered to indicate a higher level of mindfulness (Bilaç et al., 2024). The scale does not include subscales or cutoff scores. In the original study of the scale, the total Cronbach's alpha coefficient was 0.80 (Greco et al., 2011); in the Turkish adaptation study (Bilaç et al., 2024), it was found to be 0.76.

Change relative to the baseline value on day 5
Emotional Regulation Scale for Children and Adolescents
Tidsramme: Change relative to the baseline value on day 5

Developed by Gullone and Taffe (2012) as an adaptation for children and adolescents of the Emotional Regulation Scale developed by Gross and John (2003). The Turkish adaptation of the scale was conducted by Tetik and Önder (2021). There are no reverse-scored items on the scale.

Items 1, 3, 5, 7, 8, and 10 represent the reappraisal subscale; items 2, 4, 6, and 9 represent the suppression subscale. High scores on the subscales indicate that the emotion regulation strategy represented by that subscale is frequently used (Tetik and Önder, 2021). In the original version of the scale (Gullone and Taffe, 2012), the Cronbach's alpha internal consistency coefficient ranged from 0.82 to 0.86 for the reappraisal subscale and from 0.69 to 0.79 for the suppression subscale. In the Turkish adaptation study, the Cronbach's alpha internal consistency coefficient was found to be 0.79 for the reappraisal subscale and 0.53 for the suppress

Change relative to the baseline value on day 5

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Samarbeidspartnere

Etterforskere

  • Studieleder: Ebru b KILIÇARSLAN, Professor, Gazi University

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. januar 2027

Primær fullføring (Antatt)

1. juni 2027

Studiet fullført (Antatt)

1. juli 2027

Datoer for studieregistrering

Først innsendt

30. september 2026

Først innsendt som oppfylte QC-kriteriene

30. september 2026

Først lagt ut (Faktiske)

6. oktober 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

13. oktober 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

7. oktober 2026

Sist bekreftet

1. oktober 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • 2026 - 366
  • Gazi Universiyt Bap (Annen identifikator: Proje ID:11649)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere